John Y. L. Chung,Yanfeng Zhang,Laura Artino,Aaron S. Cote,Donal Desmond,Jeremy Scott,Yekaterina Vaynshteyn
申请号：
US14186829
公开号：
US09012488B2
申请日:
2014.02.21
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention relates to polymorphic forms of a compound of formula A:This compound is useful as a glucagon receptor antagonist and serves as a pharmaceutically active ingredient for the treatment of type 2 diabetes and related conditions, such as hyperglycemia, obesity, dyslipidemia, and the metabolic syndrome. Hydrates, hemihydrates, anhydrates and similar polymorphic forms are included.
